Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Leqembi
Leqembi
Eisai, Biogen's Leqembi nabs UK nod, but reimbursement remains elusive
Fierce Pharma
Thu, 08/22/24 - 11:45 am
Eisai
Biogen
Leqembi
UK
Alzheimer's disease
Driven by Leqembi, Biogen beats Q2 expectations, raises full-year outlook
Medical Marketing and Media
Thu, 08/1/24 - 11:21 pm
Biogen
earnings
Leqembi
After EU setback, Eisai/Biogen build case for Leqembi
Pharmaphorum
Wed, 07/31/24 - 10:25 am
Eisai
Biogen
Alzheimer's disease
Leqembi
Europe
Eisai 'extremely disappointed' by EMA's decision on Alzheimer's drug
Biopharma Reporter
Tue, 07/30/24 - 11:37 am
Eisai
EMA
Europe
Leqembi
Biogen
Alzheimer's disease
Eisai and Biogen's Alzheimer's med Leqembi turned down in Europe
Fierce Pharma
Fri, 07/26/24 - 11:15 am
Eisai
Biogen
Leqembi
Europe
Leqembi sales inch higher; Spark’s pivot leads to layoffs
BioPharma Dive
Fri, 07/12/24 - 11:29 am
Eisai
Biogen
Leqembi
Alzheimer's disease
Roche
Spark Therapeutics
gene therapy
layoffs
Leqembi gains approval for Alzheimer’s treatment in Israel
Pharmaceutical Business Review
Fri, 07/12/24 - 11:12 am
Eisai
Israel
Alzheimer's disease
Leqembi
BioArctic
Eisai and Biogen launch Alzheimer's drug Leqembi in China
Reuters
Fri, 06/28/24 - 11:18 am
Eisai
Biogen
Alzheimer's disease
Leqembi
China
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Fierce Pharma
Mon, 06/10/24 - 11:19 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters
Tue, 05/14/24 - 11:03 pm
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Alzheimer's drug adoption in US slowed by doctors' skepticism
Reuters
Tue, 04/23/24 - 09:47 pm
Eisai
Biogen
Leqembi
physicians
Alzheimer's disease
Lilly Alzheimer's med glides out of Leqembi's slipstream with FDA adcomm request
Fierce Biotech
Wed, 04/17/24 - 09:58 pm
Eli Lilly
donanemab
Alzheimer's disease
Leqembi
Biogen
Eisai
FDA
Biogen and Eisai Fall Behind on Leqembi’s Subcutaneous BLA for Alzheimer’s
BioSpace
Mon, 04/1/24 - 12:14 pm
Biogen
Eisai
Alzheimer's disease
Leqembi
Eisai and Biogen facing delay to Leqembi in Europe
Pharmaphorum
Mon, 03/25/24 - 11:22 am
Eisai
Biogen
Leqembi
Europe
Alzheimer's disease
Eisai backs Leqembi’s Japan rollout with insurance policy
Pharmaphorum
Thu, 03/21/24 - 11:19 am
Eisai
Lifenet
insurance
Leqembi
dementia
Tau, anti-inflammation and orals form Biogen's future Alzheimer's pipeline
Fierce Biotech
Thu, 03/7/24 - 11:38 am
Biogen
Alzheimer's disease
anti-tau antibodies
anti-inflammatory
Eisai
Leqembi
Japan's Eisai says US introduction of Alzheimer's drug Leqembi slower than expected
Reuters
Thu, 03/7/24 - 11:07 am
Eisai
Leqembi
drug launches
Alzheimer's disease
Biogen relying on success of Leqembi following discontinuation of Aduhelm
Biopharma Reporter
Mon, 03/4/24 - 11:19 am
Biogen
Leqembi
Aduhelm. Alzheimer's disease
Biogen has a fuzzy line of sight on prized Alzheimer’s drug
BioPharma Dive
Tue, 02/13/24 - 11:16 pm
Biogen
Alzheimer's disease
Leqembi
Pages
1
2
3
4
next ›
last »